CYCC - Cyclacel Pharmaceuticals Q2 2022 Earnings Preview
- Cyclacel Pharmaceuticals ( NASDAQ: CYCC ) is scheduled to announce Q2 earnings results on Tuesday, August 9th, after market close.
- The consensus EPS Estimate is -$0.67
- Over the last 3 months, EPS estimates have seen 3 upward revisions and 0 downward.
For further details see:
Cyclacel Pharmaceuticals Q2 2022 Earnings Preview